UroToday – A Meta-Analysis of Diabetes Mellitus and the Risk of Prostate Cancer
| A Meta-Analysis of Diabetes Mellitus and the Risk of Prostate Cancer BERKELEY, CA (UroToday.com) – In 2004 a meta-analysis reported that patients with diabetes mellitus (DM) had a statistically significant decrease in risk (9%) of developing prostate cancer (CaP). This has now been validated in a larger meta-analysis reported by Drs. Kasper and Giovannunucci from Harvard Medical School. Their report appears in the November 2006 issue of Cancer Epidemiology Biomarkers and Prevention. |
Diabetes is a serious illness and patients who have diabetes should make every effort to control their sugar levels. This study may be important to researchers to help figure out how prostate cancer occurs and grows.